The influence of bile acids homeostasis by cryptotanshinone-containing herbs

Similar documents
Probe substrate and enzyme source-dependent inhibition of UDPglucuronosyltransferase

In vitro assay of six UGT isoforms in human liver microsomes, using cocktails of probe substrates and LC-MS/MS

A model of in vitro UDP-glucuronosyltransferases inhibition by bile acids. predicts possible metabolic disorders

The study of phospholipids in single cells using an integrated microfluidic device

Metabolism of 1 - and 4-Hydroxymidazolam by Glucuronide Conjugation Is Largely Mediated by UDP-Glucuronosyltransferases 1A4, 2B4, and 2B7

The metabolism of 1 - and 4-hydroxymidazolam by glucuronide conjugation is. largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7

In vitro evidence of baicalein s inhibition of the metabolism of zidovudine (AZT)

Inhibition of Human Hepatic Bile Acid Transporters as Contributing Factors to Drug-Induced Liver Injury

Supplementary Material

A high-performance liquid chromatography (HPLC) method for determination of chlorogenic acid and emodin in Yinhuang Jiangzhi Tea

XTreme 200 Human Liver Microsomes Lot No Human Liver Microsomes Pool of 200 (100 Male and 100 Female) Suspension medium: 250 mm sucrose

Hepatic Transporter Proteins involved in Bile Formation

Sorafenib (free base, >99%) was obtained from Chemie Tek (Indianapolis, IN), and

Liangliang Zhu, Guangbo Ge, Hongbo Zhang, Huixin Liu, Guiyuan He, Sicheng Liang, Yanyan Zhang, Zhongze Fang, Peipei Dong, Moshe Finel, and Ling Yang

Pharmacokinetics and excretion of cryptotanshinone after intravenous injection in pigs

Improving the Drug Quality in China Via the Development of the Standard System of Pharmaceutical Exicipent of the 2015 Edition of Chinese Pharmacopeia

Screening of Monacolin K-high-yielding Monascus strain by combinative mutation treatment

Pilot experiments to investigate the glucuronidation of axitinib with human liver microsomes.

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

SIMULTANEOUS DETERMINATION OF ATORVASTATIN AND EZETIMIBE BY RP-HPLC IN PURE AND PHARMACEUTICAL DOSAGE FORM

In vitro metabolism of montelukast by Cytochrome P450s (CYPs) and UDPglucuronosyltransferases

Identification of Ginsenosides Using the SCIEX X500R QTOF System

The distribution of log 2 ratio (H/L) for quantified peptides. cleavage sites in each bin of log 2 ratio of quantified. peptides

Edgar Naegele. Abstract

Standardization of a LC/MS/MS Method for the Determination of Acyl Glucuronides and Their Isomers

Low toxicity and accumulation of zinc oxide nanoparticles in mice

Plasmonic blood glucose monitor based on enzymatic. etching of gold nanorods

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

Supporting Information

Supporting information

SUMMARY, CONCLUSION & RECOMMENDATIONS

Determination of Amantadine Residues in Chicken by LCMS-8040

Journal of Chemical and Pharmaceutical Research, 2017, 9(3): Research Article

Supporting Information. Prolonged exposure to bisphenol A from single dermal contact events

Designer Fentanyls Drugs that kill and how to detect them. Cyclopropylfentanyl

Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification

An Investigative Study of Reactions Involving Glucosinolates and Isothiocyanates

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Characterization of Disulfide Linkages in Proteins by 193 nm Ultraviolet Photodissociation (UVPD) Mass Spectrometry. Supporting Information

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

Characterization of in vitro glucuronidation clearance of a range of drugs in human kidney

SUPPLEMENTARY MATERIAL

Application Note. Authors. Abstract. Food

Separation and Quantitation of Oxysterol Compounds Using LC-MS/MS. Liquid Chromatography Mass Spectrometry SSI-LCMS-082

Supporting Information for:

Kit for assay of thioredoxin

Characterization of nuciferine metabolism by P450 enzymes and uridine diphosphate glucuronosyltransferases in liver microsomes from humans and animals

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

High Performance Liquid Chromatography-Tandem Mass Spectrometry for the Determination of Bile Acids in Mouse Serum

Application Note. Author. Abstract. Introduction. Food Safety

ZORBAX Eclipse XDB-C 18 (100 mm 4.6 mm 3.5 µm) Lichrospher-C 18 (200 mm 4.6 mm 5 µm) Megres5-C 18 (250 mm 4.6 mm 5 µm)

Supplemental Material

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Pharmacokinetic Study on Hyperoside in Beagle s Dogs

Isomeric Separation of Permethylated Glycans by Porous Graphitic Carbon (PGC)-LC-MS/MS at High- Temperatures

Received December 14, 2009; accepted March 19, 2010

Supplementary material: Materials and suppliers

Hepatic Efflux Transporters: Relevance to Drug-Drug Interactions and Drug Toxicity

Comparison of ferulic acid content in Radix Angelicae Sinensis, Danggui Buxue Tang and Danggui Sini Tang

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Determination of Trace Level of camp in Locusta Migratoria Manilensis Meyen by HPLC with Fluorescence Derivation

Supplemental material to this article can be found at:

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Bile acid metabolism. doc. Ing. Zenóbia Chavková, CSc.

TGR5 (GP-BAR1) Reporter Assay Kit

EPIGENTEK. EpiQuik HDAC Activity/Inhibition Assay Kit(Colorimetric) Base Catalog # P-4002 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

Development and Validation of a Liquid Chromatography- Mass Spectrometry method for analysis of Oxysterols in Human Plasma

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

The regulation of genes that are essential to many

Supporting information

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Biosynthesis of imipramine glucuronide and characterization of imipramine glucuronidation catalyzed by recombinant UGT1A4 1

Determination of Sedative Component in Chinese Medicines by High Resolution Chromatography-Electron Impact-Mass Spectrometry

Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS

Simultaneous Analysis of Active Pharmaceutical Ingredients and Their Counter-Ions Using a Mixed-Mode Column

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

Application Note. Commiphora mukul; Balsamodendron mukul; Commiphora wightii. Treatment of hyperlipidemia, reduction of lipid and cholesterol levels

Serum Squalene in Patients with Gallstones*)

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

In vitro metabolism of corydaline in human liver microsomes and hepatocytes using liquid chromatography-ion trap mass spectrometry

Sulfate Radical-Mediated Degradation of Sulfadiazine by CuFeO 2 Rhombohedral Crystal-Catalyzed Peroxymonosulfate: Synergistic Effects and Mechanisms

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

TWO NEW ELLAGIC ACID GLYCOSIDES FROM LEAVES OF DIPLOPANAX STACHYANTHUS

Luo et al. Received: 9 April 2015 Revised accepted: 3 January 2016

Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System

Role of metabolism in Drug-Induced Liver Injury (DILI) Drug Metab Rev. 2007;39(1):

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Bile Acid Profiling and Quantification in Biofluids using. Ultra-Performance Liquid Chromatography Tandem. Mass Spectrometry

Supporting Information. Palladium-Catalyzed Formylation of Aryl Iodides with HCOOH as

Amniotic fluid stem cells provide considerable advantages in epidermal. regeneration: B7H4 creates a moderate inflammation

Title Revision n date

Chapter 4. Drug Biotransformation

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

A biocatalytic hydrogenation of carboxylic acids

Constitutive Regulation of P450s by Endocrine Factors

A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial. Ischemia/Reperfusion Injury

Screening of Antihistamine Agents (Diphenhydramine) with Blood and Urine Samples by REMEDi-HS System

Supplementary Material (ESI) for Chemical Communications This journal is (c) The Royal Society of Chemistry 2008

Simultaneous Determination of Seven Active Components in Mian anning Mixture by HPLC Under Multiple UV Wavelengths

Transcription:

The influence of bile acids homeostasis by cryptotanshinone-containing herbs Chengcheng Gao, Tianheng Ma, Liqun Pang, Rui Xie* Department of Gastroenterology, Huai an First People s Hospital, Nanjing Medical University, 6 Beijing Road West, Huai an, Jiangsu 223300, P. R. China Abstract Background: Herbs might affect the homeostasis of bile acids through influence of multiple metabolic pathways of bile acids. Objective: To investigate the inhibition of cryptotanshinone towards the glucuronidation of LCA, trying to indicate the possible influence of cryptotanshinone-containing herbs towards the homeostasis of bile acids. Methods: The LCA-3-glucuronidation and LCA-24-glucuronidation reaction was monitored by LC-MS. Results: Initial screening showed that 100 μm of cryptotanshinone inhibited LCA-24-glucuronidation and LCA-3-glucuronidation reaction activity by 82.6% and 79.1%, respectively. This kind of inhibition behaviour exerted cryptotanshinone concentrations-dependent and LCA concentrations-independent inhibition behaviour. Conclusion: All these data indicated the possibility of cryptotanshinone s influence towards bile acids metabolism and homeostasis of bile acids. Keywords: herbs, lithocholic acid (LCA), homeostasis African Health Sciences 2014;14(1): 206-210 http://dx.doi.org/10.4314/ahs.v14i1.32 Introduction Bile acids, initiated by CYP7A1-catalyzed cholesterol oxidation in liver, exert an important role in the solubilization, absorption, and transportation of dietary lipids in the intestine 1. The most abundant bile acids in human are consisted of cholic acid (CA),chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), and lithocholic acid (LCA) 1. The homeostasis of bile acids can be tightly regulated through feed-back and feed-forward regulation pathways. Bile acids exert their toxicity towards cells at high concentrations, and the accumulation of bile acids can induce the severe damage towards liver cells 2. Bile acids have been reported to induce cell injury through many mechanisms, including the damage to the plasma membrane, oxidative stress, apoptosis, and inflammation 3,4. Among the bile acids, LCA has been commonly considered as the most toxic bile acid which has widely used as the inducer of cholestasis 5. Herbs can affect the metabolism of bile acids. For example, glycyrrhizin exhibited protective role towards LCA-induced liver injury through pregnane * Corresponding author: Rui Xie Department of Gastroenterology, Huai an First People s Hospital, Nanjing Medical University, 6 Beijing Road West, Huai an, Jiangsu 223300, P. R. China E-mail: alpinetin139@163.com X receptor (PXR) mediated-transcription regulation of cytochrome 3A which has been regarded as the most important enzyme involved in the metabolism of LCA 6. Besides CYP3A-catalyzed metabolism of LCA, glucuronidation of LCA has been regarded as another important metabolic pathway of LCA. The LCA-3-glucuronide (LCA-3G) and LCA-24-glucuronide (LCA- 24G) are the major glucuronides 7. The inhibition of the glucuronidation of LCA might increase the toxicity induced by LCA. To date, no report was given on the influence of herbs on the glucuronidation of LCA. Danshen is a perennial plant in the genus Salvia, highly valued for its roots in traditional Chinese medicine. The present study aims to evaluate the inhibition of danshen s major ingredient cryptotanshinone as an example towards the glucuronidation of LCA. Materials and Methods Reagents Lithocholic acid (LCA), uridine-5 -diphosphoglucuronic acid (UDPGA) (trisodium salt), Tris-HCl, alamethicin from Trichoderma viride (purity 98%) were purchased from Sigma-Aldrich (St Louis, MO). Pooled human liver microsomes (phlms) were purchased from BD Gentest. Cryptotanshinone was obtained from Shanghai Tauto Biotech Co. (Shanghai, China). Evaluation of inhibitory effect of cryptotanshinone towards the LCA glucuronidation reaction As previously described 8, the incubation mixture (total volume=100 μl) contained 50 mm Tris-HCl (ph=7.4), 206

10 mm MgCl 2, 25 μg of alamethicin, 0.5 mg/ml HLMs, and LCA (100 μm). All the glucuronidation incubations were performed under 37 o C for 1h. 200 μl ice-cold methanol was used to terminate the reaction. After centrifugation at 12000 rpm, the aliquots (10 μl) of supernatant were used to undergo UPLC-MS analysis. For UPLC analysis, the Shim-pack XR-ODS II column (75*2.0mm,2.2μm) was used. The flow rate was set as 0.3 ml/min. The eluents were methanol (A) and 0.2% formic acid (B) with the following gradients: 0-4 min, 35-70% A; 4-8 min, 70-80% A; 8-12min, 80-95% A; 12-15 min, 35% A. The negative mode was used to monitor LCA and its glucuronides. The ions [M-H] - 375.1 and 551.1 were selected to monitor LCA and its glucuronides, respectively. Results Under recent analysis condition, LCA was eluted at 2.3 min, and its glucuronides LCA-3-glucuronide (LCA-3 -G) and LCA-24-glucuronide (LCA-24-G) were eluted at 1.15 min and 1.35 min, respectively. 100 μm of cryptotanshinone was firstly employed to investigate the inhibition towards LCA glucuronidation. 82.6% inhibition was detected for LCA-24-glucuronidation reaction (Fig. 1), and 79.1% activity of LCA-3-glucuronidation activity was inhibited (Fig. 3). Furthermore, the inhibition capability of various concentrations of cryptotanshinone towards the glucuronidation metabolism of LCA at different concentrations was investigated. Significant dose-dependent inhibition behaviour was observed for crytotanshinone (Fig. 2), however, the concentrationdependent inhibition behaviour for the LCA concentration was not observed (Fig. 4). Fig. 1 The initial screening of cryptotanshinone s inhibitory capability towards the LCA-24-glucuronidation reaction activity. 50 μm of LCA was used, and 100 μm of cryptotanshinone was used. The data were given as mean plus S.D.. 207

Fig. 2 Different inhibitory potential of various concentrations of cryptotanshinone towards the LCA-24-glucuronidation reaction activity. Various concentrations of cryptotanshinone (0, 20, 40, 80 and 100 μm) and LCA (20, 50, 50, and 100 μm) were used. Fig. 3 The initial screening of cryptotanshinone s inhibitory capability towards the LCA-3-glucuronidation reaction activity. 50 μm of LCA was used, and 100 μm of cryptotanshinone was used. The data were given as mean plus S.D.. 208

Fig. 4 Different inhibitory potential of various concentrations of cryptotanshinone towards the LCA-3- glucuronidation reaction activity. Various concentrations of cryptotanshinone (0, 20, 40, 80 and 100 μm) and LCA (20, 50, 50, and 100 μm) were used. Discussion Multiple metabolic pathways catalyzed by enzymes contributed to the homeostasis of bile acids. The xenobiotics can affect the serum level of bile acids through influence of all these pathways, including synthesis and detoxification pathways. For example, herbs can up-regulate the activity of CYP7A1 which accelerate the synthesis of bile acids 9. Glycyrrhizin, a major ingredient of licorice, can increase the detoxification process of LCA through accelerating CYP3A-catalyzed metabolism of LCA 6. The present study focused on the glucuronidation detoxification of bile acids, using LCA as a typical substrate. LCA can undergo efficient glucuronidation process in 3-OH and 24-OH. Therefore, the inhibition potential of crytotanshinone towards both LCA-3- glucuronidation and LCA-24-glucuronidation reactions was investigated in the present study. Strong inhibition of crytotanshinone towards LCA-3-glucuronidation and LCA-24-glucuronidation was demonstrated, and this kind of inhibition was demonstrated to be crytotanshinone concentrations-dependent and LCA concentrations-independent. This result showed the possible disturbance of crytotanshinone towards the metabolism of LCA, indicating the possible influence of crytotanshinone towards the homeostasis of bile acids. It should be noted that the enzymes involved in the metabolism of LCA (e.g. UGT1A3) were also involved in the metabolism of other bile acids (e.g., chenodeoxycholic acid) 10. Therefore, danshen might also disturb the homeostasis of bile acids through inhibition of other bile acids metabolism. It should be noted that the present study results should be explained in the context of herbal complexity. Many other components in herbs might complicate the final influence of herbs towards the homeostasis of bile acids. Additionally, the long administration of herbs might also up-regulate the enzymes involved in the glucuronidation of LCA through important nuclear receptors (e.g., farnesoid X receptor (FXR), peroxisome proliferator-activated receptor alpha (PPARalpha), etc.). For example, nuclear receptor farnesoid X receptor (FXR) has been reported to activate the activity of UGT1A3 which is a key enzyme involved in the glucuronidation of LCA 10. References Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003; 72: 137-174. 2. Trottier J, Caron P, Straka RJ, Barbier O. Profile of serum bile acids in noncholestatic volunteers: genderrelated differences in response to fenofibrate. Clin Pharmacol Ther 2011; 90(2):279-286. 3. Allen K, Jaeschke H, Copple BL. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism 209

of inflammation during obstructive cholestasis. Am J Pathol 2011; 178: 175-186. 4. Perez MJ, Briz O. Bile-acid-induced cell injury and protection. World J Gastroenterol 2009; 15: 1677-1689. 5. Matsubara T, Tanaka N, Sato M, Kang DW, Krausz KW, Flanders KC, Ikeda K, Luecke H, Wakefield LM, Gonzalez FJ. TGF-β-SMAD3 signaling mediates hepatic bile acid and phospholipid metabolism following lithocholic acid-induced liver injury. J Lipid Res 2012; 53(12):2698-2707. 6. Wang YG, Zhou JM, Ma ZC, Li H, Liang QD, Tan HL, Xiao CR, Zhang BL, Gao Y. Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury. Chem Biol Interact 2012; 200(1):11-20. 7. Perreault M, Gauthier-Landry L, Trottier J, Verreault M, Caron P, Finel M, Barbier O. The Human UDP- Glucuronosyltransferase UGT2A1 and UGT2A2 Enzymes Are Highly Active in Bile Acid Glucuronidation. Drug Metab Dispos 2013; 41(9):1616-1620. 8. Caron P, Trottier J, Verreault M, Bélanger J, Kaeding J, Barbier O. Enzymatic production of bile Acid glucuronides used as analytical standards for liquid chromatography-mass spectrometry analyses. Mol Pharm 2006; 3(3):293-302. 9. Guo J, Bei W, Hu Y, Tang C, He W, Liu X, Huang L, Cao Y, Hu X, Zhong X, Cao L. A new TCM formula FTZ lowers serum cholesterol by regulating HMG- CoA reductase and CYP7A1 in hyperlipidemic rats. J Ethnopharmacol 2011; 135(2):299-307. 10. Erichsen TJ, Aehlen A, Ehmer U, Kalthoff S, Manns MP, Strassburg CP. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids. J Hepatol 2010;52(4):570-578. 210